ஏஞ்சலா கடித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஏஞ்சலா கடித்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஏஞ்சலா கடித்தல் Today - Breaking & Trending Today

Oregon Business - Biotech Sector Blooms


Biotech Sector Blooms
Shutterstock
A surge of investments in biotech companies could prove crucial to the state’s budding biotech sector and economic recovery. 
Once relegated to the realm of science fiction, the ability to manipulate a genetic sequence has become a reality. With the potential to eliminate chronic diseases, treat cancer without radiation and grow vital organs in a lab, the biotech sector has become one of the state’s fastest growing industries. 
A 2017 study by Pinnacle Economics, commissioned by the Oregon Bioscience Association, found that between private companies, public research institutions and hospitals, the biotech sector generates approximately $6.5 billion a year and creates almost 20,000 jobs annually.  ....

United States , Portland State University , San Francisco , Oregon Bioscience Association , Oregon Health Science University , Pinnacle Economics , Twist Bioscience , State University , Oregon Health , Science University , Nanostring Technologies , San Francisco Based Twist Bioscience , Angela Bitting , Oregon Business , Gene Editor , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , போர்டிலந்ட் நிலை பல்கலைக்கழகம் , சான் பிரான்சிஸ்கோ , ஓரிகந் உயிர் அறிவியல் சங்கம் , ஓரிகந் ஆரோக்கியம் அறிவியல் பல்கலைக்கழகம் , உச்சம் பொருளாதாரம் , திருப்பம் உயிர் அறிவியல் , நிலை பல்கலைக்கழகம் , ஓரிகந் ஆரோக்கியம் , அறிவியல் பல்கலைக்கழகம் ,

Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results


Search jobs
Twist Bioscience Reports First Quarter Fiscal 2021 Financial Results
SOUTH SAN FRANCISCO, Calif. (BUSINESS WIRE) #DNA Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2021 ended December 31, 2020.
“We reported a strong quarter both for orders and revenue, building a solid foundation for fiscal 2021,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “We see early evidence that our investment in synbio products for our pharmaceutical and biotech customers is beginning to gain traction, and for our NGS tools business, our liquid biopsy customers continue to drive revenue growth. Both our biopharma and DNA data storage teams made progress in advancing technologies, and we strengthened our balance sheet with ....

United States , Emilym Leproust , Jim Thorburn , Aaron Sato , Paula Green , Siyuan Chen , Facebook Linkedin Youtube , Bioscience Corporation , Us Centers For Disease , Cell Technology , Twist Bioscience Corporation , Development Expenses , Exchange Commission , Corporate Affairs , Administrative Expenses , First Quarter , Clonal Ready Gene Fragments , Gene Fragments , Gene Fragment , Disease Control , Multiplex Assay , Twist Biopharma , Chimeric Antigen Receptors , Applied Stemcell , Angela Bitting , Ginkgo Bioworks ,